Status:
NOT_YET_RECRUITING
Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section
Lead Sponsor:
Jordan Leitch
Conditions:
Cardiac Ischemia
Cesarian Section
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
The goal of this project is to examine the cardiac symptoms and physiologic changes after administration of a reduced dose of carbetocin in participants undergoing elective cesarian section. * Does r...
Eligibility Criteria
Inclusion
- Undergoing elective cesarian section
- Primary and repeat cesarian section
Exclusion
- Prior and current cardiovascular co-morbidities including pre-eclampsia
- BMI greater than 50
- Pre-existing bleeding disorders
- Allergy to carbetocin
- Age under 18
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06946589
Start Date
August 1 2025
End Date
September 1 2027
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kingston Health Sciences Centre
Kingston, Ontario, Canada, K7L 2V7